Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233
- 31 July 1988
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 12 (3), 209-218
- https://doi.org/10.1016/0167-8140(88)90263-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Molecular mechanisms for the hypoxiadependent activation of 3-amino-1,2,4-benzotriazine-1, 4-dioxide (SR 4233)Biochemical Pharmacology, 1988
- Tumor oxygenation and reoxygenation during radiation theraphy: Their importance in predicting tumor responseInternational Journal of Radiation Oncology*Biology*Physics, 1986
- RSU 1069, a nitroimidazole containing an aziridine group: Bioreduction greatly increases cytotoxicity under hypoxic conditionsBiochemical Pharmacology, 1986
- Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: A preliminary reportInternational Journal of Radiation Oncology*Biology*Physics, 1984
- The optimum time for irradiation relative to tumour concentration of hypoxic cell sensitizersThe British Journal of Radiology, 1980
- The hypoxic tumor cell: A target for selective cancer chemotherapyBiochemical Pharmacology, 1980
- Radiosensitizing and Toxic Effects of the 2-Nitroimidazole Ro-07-0582 in Hypoxic Mammalian CellsRadiation Research, 1976
- Hypoxic Sensitizers: Radiobiological Studies at the Cellular LevelRadiology, 1975
- Potential bioreductive alkylating agents. 1. Benzoquinone derivativesJournal of Medicinal Chemistry, 1972
- Simple Synthesis of 3‐Amino‐1,2,4‐benzotriazine 1,4‐DioxideAngewandte Chemie-International Edition, 1972